Literature DB >> 6170301

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.

P J Johnson, W M Melia, M K Palmer, B Portmann, R Williams.   

Abstract

An analysis of survival time of 57 West European patients with hepatocellular carcinoma was carried out to define which of several possible factors (age, sex, cirrhosis and raised serum alpha-foetoprotein (AFP)) influenced survival. Although survival was significantly longer in younger patients (P less than 0.02) and in patients with normal serum AFP (P less than 0.01), multivariate analysis showed that significant variation in survival time is better explained by the single factor, the presence of cirrhosis, than by AFP level. This does not seem to apply for patients with this tumour in Africa and the Far East, and there may be a fundamental difference in the natural history of the tumour between high- and low-incidence areas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170301      PMCID: PMC2010797          DOI: 10.1038/bjc.1981.218

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations.

Authors:  C L Vogel; A Primack; K R McIntire; P P Carbone; P P Anthony
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

2.  [Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver].

Authors:  E Ruoslahti; M Seppälä; P Vuopio; E Saksela; P Peltokallio
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

3.  Serum-alpha 1-fetoprotein in hepatocellular carcinoma.

Authors:  J Kohn; P C Weaver
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

4.  Serum alpha-feto-protein. I. Immunodiffusion and immuno-assay results in cases of primary cancer of the liver.

Authors:  L R Purves; M Macnab; I Bersohn
Journal:  S Afr Med J       Date:  1968-11-02

5.  Hepatic artery infusion chemotherapy in hepatoma.

Authors:  J L Provan; J F Stokes; D Edwards
Journal:  Br Med J       Date:  1968-08-10

6.  A clinicopathological review of 100 cases of primary malignant tumours of the liver.

Authors:  R N MacSween
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

7.  Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.

Authors:  P J Johnson; B Portmann; R Williams
Journal:  Br Med J       Date:  1978-09-02

8.  A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients.

Authors:  A Primack; C L Vogel; S K Kyalwazi; J L Ziegler; R Simon; P P Anthony
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

9.  Induction of remission in hepatocellular carcinoma with doxorubicin.

Authors:  P J Johnson; R Williams; H Thomas; S Sherlock; I M Murray-Lyon
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

  9 in total
  11 in total

1.  Spontaneous regression of hepatocellular carcinoma.

Authors:  R C Ayres; D A Robertson; K C Dewbury; G H Millward-Sadler; C L Smith
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

2.  MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

Authors:  Kentaro Kojima; Akemi Takata; Charles Vadnais; Motoyuki Otsuka; Takeshi Yoshikawa; Masao Akanuma; Yuji Kondo; Young Jun Kang; Takahiro Kishikawa; Naoya Kato; Zhifang Xie; Weiping J Zhang; Haruhiko Yoshida; Masao Omata; Alain Nepveu; Kazuhiko Koike
Journal:  Nat Commun       Date:  2011-06-07       Impact factor: 14.919

3.  Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Hepatol Int       Date:  2009-12-24       Impact factor: 6.047

4.  Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Tsutomu Tamai; Hirofumi Uto; Yoichiro Takami; Kouhei Oda; Akiko Saishoji; Masashi Hashiguchi; Kotaro Kumagai; Takeshi Kure; Seiichi Mawatari; Akihiro Moriuchi; Makoto Oketani; Akio Ido; Hirohito Tsubouchi
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

5.  Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinoma.

Authors:  Indra Bachtiar; Valentine Kheng; Gunawan A Wibowo; Rino A Gani; Irsan Hasan; Andri Sanityoso; Unggul Budhihusodo; Syafruddin Ar Lelosutan; Ruswhandi Martamala; Wenny A Achwan; Soewignyo Soemoharjo; Ali Sulaiman; Laurentius A Lesmana; Susan Tai
Journal:  BMC Res Notes       Date:  2010-11-23

6.  Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors.

Authors:  Oskar Kornasiewicz; Marcin Dębski; Michal Grat; Barbara Lenartowicz; Marta Stępnowska; Anna Szałas; Ewa Bar-Andziak; Marek Krawczyk
Journal:  Arch Med Sci       Date:  2013-08-20       Impact factor: 3.318

7.  Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.

Authors:  Aiying Zhang; Chengzeng Yin; Zhenshun Wang; Yonghong Zhang; Yuanshun Zhao; Ang Li; Huanqin Sun; Dongdong Lin; Ning Li
Journal:  J Int Med Res       Date:  2016-11-24       Impact factor: 1.671

8.  The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.

Authors:  Eun-Ran Park; Sang-Bum Kim; Jee-San Lee; Yang-Hyun Kim; Dong-Hyoung Lee; Eung-Ho Cho; Sun-Hoo Park; Chul Ju Han; Bu-Yeo Kim; Dong Wook Choi; Young Do Yoo; Ami Yu; Jae Won Lee; Ja June Jang; Young Nyun Park; Kyung-Suk Suh; Kee-Ho Lee
Journal:  Cancer Med       Date:  2017-03-23       Impact factor: 4.452

9.  microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.

Authors:  Fujun Yu; Zhongqiu Lu; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Diagn Pathol       Date:  2015-07-28       Impact factor: 2.644

10.  Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.

Authors:  Chung-Lin Hung; Chia-Shen Yen; Hung-Wen Tsai; Yu-Chieh Su; Chia-Jui Yen
Journal:  BMC Cancer       Date:  2015-10-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.